When you’re diagnosed with breast cancer, one of the biggest questions is often: “What is the risk that my cancer could come back?” The answer is not always straightforward and two breast cancers that appear very similar based on size, stage, or even subtype can behave very differently over time. This is where genomic recurrence […]

For many patients diagnosed with hormone receptor-positive breast cancer, anastrozole is a cornerstone of treatment — and understanding its effects matters from day one. Anastrozole belongs to a class of drugs called aromatase inhibitors, which work by blocking the enzyme responsible for converting androgens into estrogen. Reducing estrogen levels helps slow or stop the growth […]

Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together thousands of cancer researchers, oncologists, and advocates to discuss the latest cancer research. Some studies presented at ASCO may eventually change how breast cancer is treated. Others help answer important questions patients have been asking for years. Not every study presented at […]